MEDICATION MANAGEMENT AND QUALITY USE OF MEDICINES
Dr Manya Angley, Adjunct Professor,
School of Health and Clinical Sciences, Health Professions Education,
University of Western Australia &
Director,
Manya Angley Research and Consulting (MARAC),
Adelaide, South Australia
RESEARCHER PROFILE
Filmed in Adelaide, Australia | July 2026
Adjunct Professor Manya Angley is an Advanced Practice Pharmacist. Manya spent the first 20 years of her career as a teaching and research academic at the University of South Australia. She currently works as a credentialed pharmacist and researcher through her business, Manya Angley Research and Consulting (MARAC).
Her professional activities are focused in general practice, disability and aged care. She continues to undertake research in medicines safety at care transitions and quality use of medicines in the aged care and disability sectors. Manya has just stepped down as SA/NT Branch President of the Pharmaceutical Society of Australia (July 2023-June 2026) was previously vice-president (2022-2023).
Manya was the proud recipient of the Pharmaceutical Society of Australia (SA/NT Branch) Pharmacist of the Year (2021) and the Australian Association of Consultant Pharmacy MIMS Consultant Pharmacist of the Year (2021).
Manya holds, or has held, positions on various multidisciplinary Department of Health, Disability and Ageing (DoHDA) and the ACSQHC technical expert committees. She is regularly invited to present at National pharmacy conferences and to present to other disciplines.
Manya was appointed an Adjunct Professor at the University of Western Australia in 2025.
Source: Supplied
-
DNA repair on the Fanconi anaemia pathway
Associate Professor Wayne Crismani is an internationally recognised expert in DNA repair, with a particular focus on Fanconi anaemia (FA)—a cancer-predisposition and bone marrow failure syndrome marked by extreme sensitivity to DNA damage. Based at St Vincent’s Institute in Melbourne, he leads a research program dedicated to understanding the genetic, cellular, and reproductive consequences of FA. He is currently supported by a Victorian Cancer Agency Mid-Career Fellowship and funding from the National Health and Medical Research Council.
-
Development of novel analytical and diagnostic tools using nanotechnology and microfluidics
Dr Alain Wuethrich is an NHMRC Emerging Leader fellow and ARC DECRA awardee at the Australian Institute for Bioengineering and Nanotechnology.
Hailing from Switzerland, research focuses on the development of novel analytical and diagnostic tools that harness nanotechnology and microfluidics; two rapidly growing fields with high potential to provide diagnostic solutions needed for precision medicine.
-
Genetic disease research imitating function and architecture of organs
Professor Wolvetang was among the first to bring the first human embryonic stem cells to Queensland, with his Wolvetang Group at the AIBN now renowned for its work with organoids: growing them, studying them, and using them to try and understand diseases and human development.
Using cutting edge technology, Professor Wolvetang designs and grows organoids both for their own work and for labs across the country, coaxing pluripotent stem cells or tissue samples into 3D structures that mimic the function and architecture of real brains, livers, kidneys, spinal cords, and intestines.
